LENZ Therapeutics Inc. (LENZ)
NASDAQ: LENZ
· Real-Time Price · USD
30.18
0.07 (0.23%)
At close: Jun 27, 2025, 3:59 PM
29.65
-1.76%
After-hours: Jun 27, 2025, 05:11 PM EDT
0.23% (1D)
| Bid | 29.65 |
| Market Cap | 849.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.74M |
| EPS (ttm) | 0.66 |
| PE Ratio (ttm) | 45.73 |
| Forward PE | -10.79 |
| Analyst | Buy |
| Ask | 33.14 |
| Volume | 237,083 |
| Avg. Volume (20D) | 269,791 |
| Open | 30.27 |
| Previous Close | 30.11 |
| Day's Range | 29.65 - 30.87 |
| 52-Week Range | 16.49 - 38.93 |
| Beta | 0.41 |
About LENZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LENZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LENZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+5.48%
LENZ Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
-2.86%
LENZ Therapeutics shares are trading higher after the company announced the FDA accepted its new drug application for LNZ100 for the treatment of Presbyopia.
